A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2

Shixia Wang(Bioscience Research), Farshad Guirakhoo(Dallas VA Medical Center), Kou-Liang Hou(Asia Centre), Chang Yi Wang(Chung Hua University), Alexander Rumyantsev(Altimmune (United Kingdom)), Ming-Han Jiang(Asia University), Alexander Bukreyev(Galveston College), Hui-Kai Kuo(Asia University), Yaw-Jen Liu(CTI BioPharma (Italy)), Natalia A. Kuzmina(Galveston College), Chung Ho Hung(United Biomedical (United States)), Mei Mei Hu(United Biomedical (United States)), Jennifer Cheng(Asia University), Ed Lin(United Biomedical (United States)), Yi‐Ling Lin(Taichung Veterans General Hospital), Chandru Subramani(Galveston College), Shuang Ding(Chinese Academy of Sciences), Wei Xia(Northern Jiangsu People's Hospital), Zhonghao Shih(CTI BioPharma (Italy)), Valorie Ryan(Altimmune (United Kingdom)), Huang-Ting Wu(Asia Centre), Delphine C. Malherbe(University of Kentucky), Thomas P. Monath(Crozet BioPharma (United States)), Hui-Jung Chen(CTI BioPharma (Italy)), Michael Hellerstein(ExxonMobil (United States)), Lin Feng(Peking University), Be-Shen Kuo(CTI BioPharma (Italy)), Zhi Liu(United Biomedical (United States)), Ya-Ting Yang(Asia University), Tony Chen(University of Maryland, College Park), Juin-Hua Huang(Asia University), Min-Sheng Wang(Wuhan University), Sivakumar Periasamy(Albany Medical Center Hospital), D. Gray Heppner(Dallas VA Medical Center), Wen‐Jiun Peng(Asia University)
Emerging Microbes & Infections
October 26, 2022
Cited by 33


Related Papers